Abivax SA (ABVX) Stock: Buy, Sell, or Hold?
ABVX - Abivax SA American Depositary Shares
$90.89
-1.99 (-2.14%)
▼
5d:
-6.15%
30d:
-20.3%
90d:
-36.07%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Sep 21, 2026
0d
Get Alerted When ABVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABVX is currently trading at $90.89, which is considered oversold relative to its 30-day fair value range of $99.10 to $116.76.
Technical Outlook: Technically, ABVX is in a strong uptrend. The price is currently testing key support at $90.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABVX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $164.00 (+76.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABVX is in a strong uptrend. The price is currently testing key support at $90.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ABVX scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $164.00 (+76.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$99.10 -
$116.76
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 76.6% below Wall St target ($164.00)
- CAUTION: Bottoming setup, but lagging the sector by 33% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$99.10 -
$116.76
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$90.96
Resistance Level
$105.72
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-23.93
Wall Street Target
$164.00
(+76.6%)
Revenue Growth (YoY)
-6.8%
Share & Embed Analysis
Last updated: October 05, 2026 10:32 AM ET
Data refreshes hourly during market hours. Next update: 11:32 AM
Data refreshes hourly during market hours. Next update: 11:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
23 analysts |
$84 | 71 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
15 analysts |
$52 | 66 BUY |
|
TSHA
Taysha Gene Therapies Inc |
STRONG BUY
13 analysts |
$13 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
